Lilly Aims to Produce 100K Covid-19 Antibody Doses by Year End: CFO

Jul.30 — Eli Lilly Chief Financial Officer Joshua Smiley says the drugmaker expects to start registratrion trials of its coronavirus antibody treatment “within the next few weeks” and to produce 100,000 doses of a successful therapeutic by the end of 2020. He speaks on “Bloomberg Markets: European Close.”

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

  • Vaccines for emergency use – WHO Press Conference (15 February 2021)
  • UK moves to next phase of COVID-19 vaccine rollout
  • Mexico begins vaccinating elderly against Covid-19
  • Serbia honors Chinese physicians on Statehood Day
  • Coronavirus: Scott Morrison confirms TGA approval of AstraZeneca vaccine | 9 News Australia
  • Leave a Comment